30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Solis Pharma US Inc (none)

Stock chart
Ticker: none


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
MB Americus LLC
frmer sh
1 sale — total 9,604 USD
Sale 30 Sep 2013
Value US$4,248,344.43 | Price 231.59 | Shares 59,232
Sale 30 Sep 2013
Value US$3,176,237.10 | Price 152.45 | Shares 4,027
Sale 30 Sep 2013
Value US$9,604,000,000.00 | Price 980.00 | Shares 9,800,000
Sale 30 Sep 2013
Value US$9,604,000,000.00 | Price 980.00 | Shares 9,800,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2015-09-24 2013-09-30 S Sale MB Americus LLC

frmer sh

59,232 -49.4%
231.59
US$4,248,344
59,232 -49.4% 231.59 US$4,248,344
2014-02-20 2013-09-30 S Sale Tiber Creek CORP

former 10% owner

4,027 +32.2%
152.45
US$3,176,237
4,027 +32.2% 152.45 US$3,176,237
2014-02-20 2013-09-30 S Sale CASSIDY JAMES M

former officer and director

98,239 +3.4%
275.52
US$4,643,929
98,239 +3.4% 275.52 US$4,643,929
2014-02-20 2013-09-30 S Sale McKillop James K

former officer and director

9,800,000 -98.0%
980.00
US$9,604,000,000
9,800,000 -98.0% 980.00 US$9,604,000,000
Explore more

More insider trading research around Solis Pharma US Inc